BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oon CE, Bridges E, Sheldon H, et al. (2017) Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth. Oncotarget |
| Siriwardana PN, Luong TV, Watkins J, et al. (2016) Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin. Medicine. 95: e2924 |
| Tan K, Haider S, Zois C, et al. (2016) NUB1 protein regulates cullins and E3 ligases in estrogen receptor negative breast cancers European Journal of Cancer. 61: S190 |
| Siriwardana P, Luong T, Watkins J, et al. (2016) Ten-year follow up case-control study of the effect of portal vein embolisation on the survival of patients with colorectal liver metastases; the hypoxia factor influence Hpb. 18: e3 |
| Fan SJ, Snell C, Turley H, et al. (2015) PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer. Oncogene |
| Bazzola L, Foroni C, Andreis D, et al. (2015) Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer. British Journal of Cancer. 112: 52-60 |
| Stevens D, Verrill C, Bryant R, et al. (2015) MP55-12 THE PROTON-ASSISTED AMINO ACID TRANSPORTER 4 (PAT4/SLC36A4) IS UP-REGULATED IN PROSTATE CANCER Journal of Urology. 193 |
| Kato T, Pezzella F, Steers G, et al. (2014) Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer. International Journal of Clinical and Experimental Pathology. 7: 7967-78 |
| Adighibe O, Turley H, Leek R, et al. (2014) JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues. Virchows Archiv : An International Journal of Pathology. 465: 715-22 |
| Feldinger K, Generali D, Kramer-Marek G, et al. (2014) ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer. Oncotarget. 5: 6633-46 |